Novel Brain Cancer Vaccine Shows Promising Results in Phase 1 Human Trials Medicine & Technology Mar 24, 2021 An intravenous brain cancer vaccine that first began human clinical trials in 2015 now reports significant promise of assisting patients' immune response in targeting brain tumors.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts